2,755
Views
5
CrossRef citations to date
0
Altmetric
Reproductive Medicine

FDA approved vs. Pharmacy compounded 17-OHPC—current issues for obstetricians to consider in reducing recurrent preterm birth

, &
Pages 1393-1401 | Received 22 Apr 2020, Accepted 07 Jun 2020, Published online: 30 Jun 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.